Alumis ALMS
NASDAQ ALMS
$11.10 -0.26 (-2.29%)
As of: Sep 4, 2026 · 3:59 PM EDT

Alumis (ALMS) Retained Earnings (2023 - 2026)

Alumis (ALMS) posted quarterly Retained Earnings of -$901.9 million for Q4 2025, down 36.95% year-over-year from -$1.4 billion in Q4 2024, and down 11.49% quarter-over-quarter from -$808.9 million in Q3 2025.

Analysis

Alumis (ALMS) Retained Earnings (2023 - 2026) Analysis & Trends

Alumis (ALMS) has reported Retained Earnings for 3 consecutive years, with -$901.9 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Retained Earnings fell 36.95% year-over-year to -$901.9 million; the TTM figure through Dec 2025 stood at -$901.9 million (down 36.95% YoY), while the FY2025 annual figure was -$901.9 million, down 36.95% from the prior year.
  • Retained Earnings declined to -$901.9 million in Q4 2025 per ALMS's latest filing, from -$808.9 million in the prior quarter.
  • Across five years, Retained Earnings topped out at $925.8 million in Q1 2025 and bottomed at -$901.9 million in Q4 2025.
  • Historically, Retained Earnings has averaged -$326.5 million across 3 years, with a median of -$564.6 million in 2024.
  • Annual changes were most pronounced in 2024 — Retained Earnings plunged 32927650.0% — and 2025, when it tumbled 36.95%.
  • Alumis' Retained Earnings stood at $2000.0 in 2023, then slumped by 32927650.0% to -$658.6 million in 2024, then slumped by 36.95% to -$901.9 million in 2025.
  • Business Quant data shows ALMS's Retained Earnings at -$901.9 million in Q4 2025, -$808.9 million in Q3 2025, and -$698.2 million in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 15.69 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 37.62 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 558.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.10 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -4.00 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 13.05 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -6.33 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 4.38 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 6.57 Bn
10 Alumis 1.42 Bn 919.00 Mn - 1.59 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.59 Bn
Dec 31, 2025 1.20 Bn
Sep 30, 2025 1.19 Bn
Jun 30, 2025 1.18 Bn
Mar 31, 2025 925.83 Mn
Dec 31, 2024 918.61 Mn
Sep 30, 2024 912.04 Mn
Jun 30, 2024 -470.70 Mn
Dec 31, 2023 -364.32 Mn